In the first episode of the official Directors & Boards podcast, Executive Session, Bill Hayes, editor in chief of Directors & Boards, talks to three experts in the field of corporate governance. First up is Josh Klein, advisory board member of BP, on AI. Anna Catalano, director and nom/gov chair of Ecovyst Inc., walks us through issues around board refreshment. Wrapping up the show is Charles Elson, director of Enhabit Home Health and Hospice and Blue Bell Creameries (as well as executive editor at large of Directors & Boards), who addresses the situation surrounding Delaware’s status as the home of corporate law.
Don’t miss an episode! Follow the Executive Session podcast on Spotify, iHeartRadio, Apple Podcasts, or anywhere else you get your podcasts.
Guests
Josh Klein
Josh Klein is an advisory board member of BP and Eyrir Venture Management, CEO of people analytics firm Indigometrics and founder of H4X Industries, a technology strategy consultant.
Anna Catalano
Anna Catalano is a director and chair of the nom/gov committee of Ecovyst, director and chair of the compensation committee of Frontdoor Inc., and director of Hexion Inc., HF Sinclair Corporation and Clareo. She is also an advisory board member of Penta Group and Knoebel Institute for Healthy Aging.
Charles Elson
Charles Elson is a director of Enhabit Home Health and Hospice Corporation and Blue Bell Creameries Inc. He is also executive editor-at-large of Directors & Boards. Elson is the retired Edgar S. Woolard Jr. Chair in Corporate Governance and the Founding Director of the John L. Weinberg Center for Corporate Governance at the University of Delaware.
Sponsored by
